Skip to main content

Year: 2022

Shell Plc Third Quarter 2022 Euro and Gbp Equivalent Dividend Payments

SHELL PLC THIRD QUARTER 2022 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS   December 5, 2022   The Board of Shell plc (“Shell”) today announced the pounds sterling and euro equivalent dividend payments in respect of the third quarter 2022 interim dividend, which was announced on October 27, 2022 at US$0.25 per ordinary share.   Shareholders have been able to elect to receive their dividends in US dollars, euros or pounds sterling. Holders of ordinary shares who have validly submitted US dollars, euros or pounds sterling currency elections by November 25, 2022 will be entitled to a dividend of US$0.25, €0.2398 or 20.61p per ordinary share, respectively.   Absent any valid election to the contrary, persons holding their ordinary shares through Euroclear Nederland will receive their dividends in euros at the euro rate per ordinary share shown...

Continue reading

Sampo plc’s share buybacks 02/12/2022

SAMPO PLC                 STOCK EXCHANGE RELEASE         05/12/2022 at 08:30 am Sampo plc’s share buybacks 02/12/2022 On 02/12/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  13,822 48.47 AQEU  30,086 48.47 CEUX  15,160 48.50 TQEX  71,567 48.46 XHELTOTAL 130,635 48.47  *rounded to two decimals                 On 9 June 2022, Sampo announced a share buyback programme of up to a maximum of EUR 1 billion in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 10 June 2022, is based...

Continue reading

CGG Announces New Integrated Multi-Client Data Project in Southeast Arizona to Support Mining Industry

Paris, France – December 5, 2022 CGG, a global technology and Earth sciences leader, has announced a new multi-client data project in Southeast Arizona focusing on exploration and development in the mining industry. The project, supported by industry funding and available to license now, will begin immediately, with final products scheduled for delivery through CGG’s proprietary GeoVerse™ platform. Dechun Lin, EVP, Earth Data, CGG, said: “Our Southeast Arizona data project represents a significant step forward in our strategy to provide integrated data solutions for the mining industry and is an innovative and effective model to improve data access in critical mining regions.” As part of this project, CGG will acquire over 270,000 line-kilometers of new airborne multi-physics data, including aeromagnetic, radiometric and airborne...

Continue reading

ForFarmers N.V.: ForFarmers convenes Extraordinary General Meeting of Shareholders on 17 January, 2023

Lochem, 5 December, 2022 ForFarmers convenes Extraordinary General Meeting of Shareholders on 17 January, 2023  ForFarmers N.V. announces that Extraordinary General Meeting of Shareholders will be held (as a virtual meeting) on Tuesday 17 January, 2023, starting at 10.00 am (CET) in relation to the appointment of Theo Spierings as member of the Executive Board (CEO). The convocation announcement and the agenda and explanatory notes to the agenda are available via the corporate website of ForFarmers (www.forfarmersgroup.eu/en) under Investors / General Meeting of Shareholders.  This press release contains information that qualifies as inside information within the meaning of Article 7 paragraph 1 of the EU Market Abuse Regulation.  Note to the editor / For additional information: Caroline Vogelzang, Director Investor Relations  M: 0031...

Continue reading

Novartis PluvictoTM shows statistically significant and clinically meaningful radiographic progression-free survival benefit in patients with PSMA–positive metastatic castration-resistant prostate cancer

Ad hoc announcement pursuant to Art. 53 LRPhase III PSMAfore trial with PluvictoTM met the primary endpoint of radiographic progression-free survival (rPFS) in PSMA–positive mCRPC who have been treated with androgen-receptor pathway inhibitor (ARPI) therapy1Pluvicto becomes the first PSMA-targeted radioligand therapy to demonstrate clinical benefit in mCRPC patients before receiving taxane-based chemotherapy1, addressing a significant unmet need2Findings to be presented at an upcoming medical meeting and submitted to regulatory authorities for approval in 2023Novartis is advancing a broad portfolio of radioligand therapies to treat cancer and is investing in manufacturing capacity to meet the growing global demand for treatmentBasel, December 5, 2022 — Today, Novartis announced the pivotal Phase III PSMAfore study with PluvictoTM...

Continue reading

TOP Ships Announces Pricing of $13.5 Million Public Offering

ATHENS, Greece, Dec. 04, 2022 (GLOBE NEWSWIRE) — TOP Ships Inc. (NASDAQ: TOPS) (the “Company”), an international owner and operator of modern, fuel efficient “ECO” tanker vessels, announced today the pricing of a public offering of 6,750,000 units at a price of $2.00 per unit. Each unit consists of one common share and one Class C warrant to purchase one common share, and will immediately separate upon issuance. The gross proceeds of the offering to the Company, before discounts and commissions and estimated offering expenses, are expected to be approximately $13.5 million. Each Class C warrant is immediately exercisable for one common share at an exercise price of $2.00 per share and will expire five years from issuance. The offering is expected to close on or about December 6, 2022, subject to customary closing conditions. Maxim...

Continue reading

Correction: Advantest Unveils E5620 DR-SEM for Review and Classification of Ultra-Small Photomask Defects

TOKYO, Dec. 03, 2022 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) today unveiled the E5620 Defect Review Scanning Electron Microscope (DR-SEM), its newest mask SEM product for reviewing and classifying ultra-small defects on photomasks and mask blanks. With its high-accuracy, high-throughput defect review capability, the E5620 DR-SEM is expected to contribute appreciably to production quality improvements in next-generation photomasks and shorter mask manufacturing turnaround times. Like its predecessor, the E5620 implements Advantest’s highly stable image capture technology to easily import defect location data from mask inspection systems and automatically image the locations. The system has a number of improvements specifically to target future mask requirements. “In working...

Continue reading

Coastal Capital Acquisition Corporation Reverse Stock Split

JACKSONVILLE, Fla., Dec. 02, 2022 (GLOBE NEWSWIRE) — Coastal Capital Acquisition Corporation (OTCMKTS: CCAJ) (“the Company”), is currently listed on the OTC Markets (OTCMKTS) with its symbol CCAJ. The Company, as of December 1, 2022, has submitted to FINRA a Reverse Stock Split with every ten (10) shares of outstanding common shares held by each shareholder will automatically be converted into one (1) common stock. No fractional shares will be issued in connection with the reverse stock split and the par value remains unchanged. All fractional shares will be rounded up. Shareholders holding stock certificates may contact the Company’s transfer agent, Pacific Stock Transfer Company for details on how to exchange for new stock certificates. Coastal Capital Acquisition Corporation believes it is placed precisely, in terms of long-term...

Continue reading

Brookfield Announces Reset Dividend Rate on Its Series 30 and Series 48 Preference Shares

All amounts in Canadian dollars unless otherwise stated. BROOKFIELD, NEWS, Dec. 02, 2022 (GLOBE NEWSWIRE) — Brookfield (NYSE: BAM, TSX: BAM.A) today announced that it has determined the fixed dividend rate on its Cumulative Class A Preference Shares, Series 30 (“Series 30 Shares”) (TSX: BAM.PR.Z) for the five years commencing January 1, 2023 and ending December 31, 2027, and also determined the fixed dividend on its Cumulative Class A Preference Shares, Series 48 (“Series 48 Shares”) (TSX: BAM.PF.J) for the five years commencing January 1, 2023 and ending December 31, 2027. As previously disclosed, the Series 30 Shares and Series 48 Shares are expected to commence trading on the TSX under the updated symbols “BN.PR.Z” and “BN.PF.J”, respectively, on December 12, 2022. Series 30 Shares and Series 31 Shares If declared, the fixed...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.